Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GenDerm's Zonalon (doxepin cream, 5%)

Executive Summary

Topical antihistamine expected to be in pharmacies by the end of April following April I approval. Direct price to wholesalers for a 30 g tube is $16.50, GenDerm says. Cream is indicated for "short-term (up to eight days) management of moderate pruritus in adult patients with the following forms of eczematous dermatitis: atopic dermatitis and lichen simplex chronicus," labeling states. Labeling warns that "drowsiness occurs in over 20% of patients treated with Zonalon cream, especially in patients receiving treatment to greater than 10% of their body surface area"

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel